- Home
- EXAS vs ARMK Comparison
EXAS vs ARMK Comparison
Compare EXAS & ARMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- ARMK
- Stock Information
- Founded
- EXAS 1995
- ARMK 1959
- Country
- EXAS United States
- ARMK United States
- Employees
- EXAS N/A
- ARMK N/A
- Industry
- EXAS Medical Specialities
- ARMK Restaurants
- Sector
- EXAS Health Care
- ARMK Consumer Discretionary
- Exchange
- EXAS Nasdaq
- ARMK Nasdaq
- Market Cap
- EXAS 11.0B
- ARMK 10.1B
- IPO Year
- EXAS N/A
- ARMK 2013
- Fundamental
- Price
- EXAS $63.46
- ARMK $40.02
- Analyst Decision
- EXAS Strong Buy
- ARMK Strong Buy
- Analyst Count
- EXAS 21
- ARMK 9
- Target Price
- EXAS $68.52
- ARMK $45.67
- AVG Volume (30 Days)
- EXAS 2.0M
- ARMK 2.3M
- Earning Date
- EXAS 11-03-2025
- ARMK 11-17-2025
- Dividend Yield
- EXAS N/A
- ARMK 1.05%
- EPS Growth
- EXAS N/A
- ARMK 3.13
- EPS
- EXAS N/A
- ARMK 1.36
- Revenue
- EXAS $2,939,949,000.00
- ARMK $17,874,782,000.00
- Revenue This Year
- EXAS $16.68
- ARMK $9.19
- Revenue Next Year
- EXAS $12.15
- ARMK $5.76
- P/E Ratio
- EXAS N/A
- ARMK $29.53
- Revenue Growth
- EXAS 12.55
- ARMK 4.02
- 52 Week Low
- EXAS $38.81
- ARMK $29.92
- 52 Week High
- EXAS $72.83
- ARMK $44.49
- Technical
- Relative Strength Index (RSI)
- EXAS 80.15
- ARMK 59.74
- Support Level
- EXAS $60.39
- ARMK $38.15
- Resistance Level
- EXAS $62.31
- ARMK $40.30
- Average True Range (ATR)
- EXAS 1.55
- ARMK 0.99
- MACD
- EXAS 0.29
- ARMK 0.09
- Stochastic Oscillator
- EXAS 91.33
- ARMK 63.28
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About ARMK Aramark
Aramark, founded in 1936 and headquartered in Philadelphia, Pennsylvania, operates as a food service company providing facility management and workplace solutions. The company primarily generates revenue from its North American food and support services segment, serving various clients including schools, healthcare facilities, and entertainment venues.